InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Mexico

  • Mexico and the TPP

    Jorge Vega, Eduardo Castañeda and Guillermo González of Basham Ringe and Correa explain how the Trans-Pacific Partnership would affect Mexico’s IP system

  • Mexican law and practice related to patent eligible subject matter

    Héctor Chagoya and Claudia Campos of Becerril Coca & Becerril discuss the features of the Mexican patent system under a new environment for human creativity recognition, and analyse statutory provisions given the scarcity of administrative or judiciary precedents available for interpreting Mexican law

  • Madrid System and Mexico’s opposition system

    Laura Collada and Ariadna Galvez of Dumont Bergman Bider & Co discuss Mexico’s experience of the Madrid System since 2013 and point out some flaws in its new opposition system

  • Information technology and proving trade mark use

    Enrique Romano Barragán of Goodrich discusses the importance of information technology as evidence to prove trade mark use in cancellation actions on grounds of lack of use according to Mexican law

  • Why online marketplaces should implement IP protection programmes

    Fernanda Díaz and Víctor Ramírez of Olivares discuss the role and responsibilities of online intermediaries in connection with IP rights in Mexico


profile

Managing IP

ManagingIP

ManagingIP profile

RT @mdloney: SCOTUS TC Heartland v Kraft Foods Group Brands oral argument transcript is up! https://t.co/v29vEKCILp

Mar 27 2017 07:50 ·  reply ·  retweet ·  favourite
ManagingIP profile

Likely to be an important question for some applicants, with UPC due to come into force in December this year https://t.co/ASuSYUpRqd

Mar 27 2017 04:40 ·  reply ·  retweet ·  favourite
ManagingIP profile

Don't forget to sign up for our next webinar, on IP in Asia, this Thursday at 3pm (London) https://t.co/gh3Ka8t9q1 @inoviaIP @Minesoftnews

Mar 27 2017 04:38 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


March 2017

Roundtable: The second medical use challenge – full transcript

Three leading patent specialists discussed one of the most challenging issues in IP at the moment – incentivising new uses for known drugs – at a recent roundtable discussion. The participants were: Jurgen Dressel, head of global patent litigation strategy, Novartis Pharma; Galit Gonen, VP and general counsel for Europe at Teva; and Professor Sir Robin Jacob, former Court of Appeal judge and professor at the Institute of Brand and Innovation Law, University College London



Most read articles

Supplements